Clinical outcomes of twice-weekly teriparatide acetate administration in osteoporosis

20250 citationsJournal Articlehybrid Open Access

Authors

Ayako Tominaga · Tokyo Women's Medical University

Hideyuki Maruki · Dainichiseika (Japan)

Keiji Wada · Tokyo Women's Medical University

Yasushi Terayama

Hideharu Nishi

Yoshiharu Kato

Ken Okazaki · Tokyo Women's Medical University

Abstract

The continuation rate of W2TPD was 47% and resulted in particularly favorable BMD gains in the spine. It was also discovered to be effective in increasing BMD even when following bisphosphonate treatment.

Topics & Keywords

Bone health and osteoporosis research Bone health and treatments Bone and Joint Diseases

Publication Details

Published in: Archives of Osteoporosis

Volume 20, Issue 1, pp. 144-144

DOI: 10.1007/s11657-025-01622-4

Field-Weighted Citation Impact: 0.00

Command Palette

Clinical outcomes of twice-weekly teriparatide acetate administration in osteoporosis

Authors

Abstract

Topics & Keywords

Publication Details